首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Discover oncology

缩写:

ISSN:N/A

e-ISSN:2730-6011

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4657
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jiaxin Guo,Zhansheng Zhu,Nanyang Tong et al. Jiaxin Guo et al.
Glioblastoma (GBM), the most aggressive primary brain tumor, develops within a tumor microenvironment (TME) dominated by tumor-associated macrophages (TAMs) that critically influence disease progression. Through single-cell RNA sequencing (...
Yangjun Yin,Maixuan Qiu,Jun Shen et al. Yangjun Yin et al.
Background: Mitophagy plays a vital role in hepatocellular carcinoma (HCC) progression. This study aims to construct a mitophagy-related scoring system and evaluate its prognostic value, association with tumor immune acti...
Hong Wei,Zhuo Zhang,Xueli Liu et al. Hong Wei et al.
Background: Although Arsenic trioxide (ATO) has revolutionized acute promyelocytic leukaemia (APL) from a uniformly fatal disease to one of the most curable leukemias, leukocytosis is a common life-threatening side effect...
Li Xu,Danting Zheng,Jisong Zhang et al. Li Xu et al.
Background: Lung adenocarcinoma (LUAD) is a highly heterogeneous disease, bringing daunting challenges in prognosis prediction. Alterations in mitochondrial dynamics (MD) are crucial in tumor generation and progression. T...
Hwal-Seok Choi,Yongjun Lee,Jin-Woo Choi et al. Hwal-Seok Choi et al.
Tumor-associated high endothelial venules (TA-HEVs) mediate lymphocyte trafficking into tumors and modulate the tumor microenvironment, with reported effects on clinical outcomes. However, reports have described discordant associations acro...
Selami Bayram,Bahadir Koylu,Maral Martin Mildanoglu et al. Selami Bayram et al.
Background: Trifluridine/tipiracil (FTD/TPI; TAS-102) is an established later-line treatment option for refractory metastatic colorectal cancer (mCRC), and randomized evidence supports the addition of bevacizumab. However...
Antonia L Stengler,Jörg Kleeff,Lisa Rieder et al. Antonia L Stengler et al.
Background: During the COVID-19 pandemic, prioritization of COVID-19 patients led to delays in oncological surgery, potentially impacting patient outcomes. This analysis examines the effects of surgical delays in various ...
Yuanhan Wang,Long Li,Xing Hu et al. Yuanhan Wang et al.
Background: Glioma exhibits significant molecular heterogeneity, necessitating improved understanding of molecular subtypes for personalized treatment strategies. ...
Shaimaa Gamal Gahin,Mostafa S Ibrahim,Eman Badr Shaimaa Gamal Gahin
Background: Ovarian cancer (OC) remains one of the most lethal gynecological cancers worldwide. Despite advances in diagnosis, OC is mostly detected at late stages due to undefined symptoms. Therefore, identifying feasibl...
Wenshuai Zheng,Rui Qin,Hang Dong et al. Wenshuai Zheng et al.
Background: Hematologic malignancies, including leukemia, non-Hodgkin lymphoma (NHL), multiple myeloma (MM), and Hodgkin lymphoma (HL), represent some of the most prevalent cancers. This study aims to comprehensively anal...